TScan Therapeutics (TCRX) Debt Ratio (2022 - 2025)
Historic Debt Ratio for TScan Therapeutics (TCRX) over the last 4 years, with Q3 2025 value amounting to 0.12.
- TScan Therapeutics' Debt Ratio rose 4037.3% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year increase of 4037.3%. This contributed to the annual value of 0.09 for FY2024, which is 2172.56% down from last year.
- Per TScan Therapeutics' latest filing, its Debt Ratio stood at 0.12 for Q3 2025, which was up 4037.3% from 0.11 recorded in Q2 2025.
- In the past 5 years, TScan Therapeutics' Debt Ratio registered a high of 0.18 during Q3 2022, and its lowest value of 0.08 during Q2 2024.
- Over the past 4 years, TScan Therapeutics' median Debt Ratio value was 0.11 (recorded in 2025), while the average stood at 0.12.
- Its Debt Ratio has fluctuated over the past 5 years, first crashed by 4151.58% in 2023, then soared by 4037.3% in 2025.
- TScan Therapeutics' Debt Ratio (Quarter) stood at 0.15 in 2022, then fell by 24.95% to 0.11 in 2023, then decreased by 21.73% to 0.09 in 2024, then surged by 43.04% to 0.12 in 2025.
- Its Debt Ratio was 0.12 in Q3 2025, compared to 0.11 in Q2 2025 and 0.1 in Q1 2025.